K

Kymera Therapeutics

Biotech company engineering targeted protein degraders

Director or Senior Director - CMC Program Management

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeWatertown, MA, USAIn-person

About the Job

Requirements

  • CMC program/project management experience for oral small molecule programs, including advancing programs through Phase 3, NDA/MAA submission, process validation, and approval.
  • Broad CMC technical knowledge spanning drug substance, drug product, and analytical development, with the ability to challenge assumptions, assess risk, and support troubleshooting.
  • Prior experience working with contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs), technology transfer, good manufacturing practice (GMP) manufacturing, and commercial supply management.
  • Working knowledge or experience in global CMC regulatory requirements and expectations, including FDA, EMA, and ICH; GMP/GLP compliance; and inspection readiness.
  • Proven ability to manage complex, cross-functional programs and translate technical concepts into executable plans.
  • Proficiency with project management tools such as MS Project, Smartsheet, or equivalent for integrated timeline and resource planning.

Responsibilities

  • Drive end-to-end CMC program management for mid- to late-stage programs, including timeline development, critical path identification, risk assessment, and execution tracking.
  • Build and maintain integrated plans spanning drug substance, drug product, analytical, quality, regulatory, and supply chain workstreams.
  • Support planning and execution of Phase 3, registration and validation campaigns, commercial-scale technology transfer, and commercial readiness activities for oral solid dosage forms.
  • Conduct CMC team meetings and ensure clear, timely communication of status, risks, decisions, and issues.
  • Participate in CDMO/CRO meetings to monitor status, action items, and risks, ensure alignment with CMC plans, and proactively identify items requiring action.
  • Coordinate preparation, review, and on-time delivery of CMC components for global regulatory filings in partnership with Regulatory Affairs and subject matter experts.
  • Serve as the CMC timeline and deliverables point of contact for CMC function leads, core team program managers, and cross-functional partners.
  • Develop CMC best practices for decision-making and scenario planning.
  • Promote a culture of cross-functional collaboration and execution excellence.

Desired Qualifications

  • An advanced degree in pharmaceutics, pharmaceutical sciences, chemistry, chemical engineering, or a related discipline is preferred, but not required with 10+ years of CMC experience.
  • For the Senior Director level, commensurate additional experience and demonstrated scope are expected.

About the Company

Kymera Therapeutics

Biotech company engineering targeted protein degraders

Kymera Therapeutics develops therapies that remove disease-causing proteins using targeted protein degradation. The company’s Pegasus Platform helps identify which proteins to degrade and then uses molecules that recruit the cell’s waste machinery to break down those proteins, aiming to treat cancers and immune diseases. This approach can create multiple drug candidates across different diseases. Kymera’s products are advanced through collaborations, most notably with Sanofi, which supports research, licensing, and milestone-based payments. Unlike traditional drugs that inhibit a protein’s function, Kymera’s strategy eliminates the protein itself, potentially offering new treatment options for patients. The company’s goal is to deliver new, effective medicines by degrading harmful proteins, expanding options in the biopharmaceutical market and addressing unmet medical needs.

Company size
201-500
Company stage
IPO
Headquarters
Watertown, MA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Kymera Therapeutics

See more jobs